Trifunctional bispecific antibody-induced tumor cell lysis of squamous cell carcinomas of the upper aerodigestive tract

Head and Neck

Volumn 27, Issue 5, 2005, Pages 376-382

  Gronau, Silke S ^a   Schmitt, Michael ^a   Thess, Bernard ^a   Reinhardt, Peter ^a   Wiesneth, Markus ^a   Schmitt, Anita ^a   Riechelmann, Herbert ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Bispecific antibodies; Chorioallantois membrane; Head and neck squamous cell carcinoma; Immunotherapy

Indexed keywords

BISPECIFIC ANTIBODY; CD3 ANTIGEN; CISPLATIN; EPITHELIAL CELL ADHESION MOLECULE; IMMUNOGLOBULIN;

ARTICLE; CELL SUSPENSION; CELL TYPE; CHILD; CHORIOALLANTOIS; CYTOLYSIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SQUAMOUS CELL CARCINOMA; T LYMPHOCYTE ACTIVATION; TUMOR CELL CULTURE; UPPER GASTROINTESTINAL TRACT; UPPER RESPIRATORY TRACT;

ANTIBODIES, BISPECIFIC; ANTIGENS, NEOPLASM; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CELL ADHESION MOLECULES; CELL SURVIVAL; CISPLATIN; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; TUMOR CELLS, CULTURED;

EID: 17844384517     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/hed.20170     Document Type: Article

References (20)

1. Lindhofer H, Mocikat R, Steipe B, Thierfelder S. Preferential species-restricted heavy/light chain pairing in rat/mouse quadromas. Implications for a single-step purification of bispecific antibodies. J Immunol 1995;155:219-225.
2. Lindhofer H, Menzel H, Gunther W, Hultner L, Thierfelder S. Bispecific antibodies target operationally tumor-specific antigens in two leukemia relapse models. Blood 1996;88:4651-4658.
3. Zeidler R, Mysliwietz J, Csanady M, et al. The Fc-region of a new class of intact bispecific antibody mediates activation of accessory cells and NK cells and induces direct phagocytosis of tumour cells. Br J Cancer 2000;83:261-266.
4. Zeidler R, Reisbach G, Wollenberg B, et al. Simultaneous activation of T cells and accessory cells by a new class of intact bispecific antibody results in efficient tumor cell killing. J Immunol 1999;163:1246-1252.
5. Zeidler R, Mayer A, Gires O, et al. TNFalpha contributes to the antitumor activity of a bispecific, trifunctional antibody. Anticancer Res 2001;21:3499-3503.
6. Riesenberg R, Buchner A, Pohla H, Lindhofer H. Lysis of prostate carcinoma cells by trifunctional bispecific antibodies (alpha EpCAM × alpha CD3). J Histochem Cytochem 2001;49:911-917.
7. Ruf P, Lindhofer H. Induction of a long-lasting antitumor immunity by a trifunctional bispecific antibody. Blood 2001;98:2526-2534.
8. Gual A, Eugenin J, Alcayaga J, Stensaas LJ, Eyzaguirre C. The chick chorioallantoic membrane promotes survival of co-transplanted rat carotid bodies and nodose ganglia. Brain Res 1991;556:139-144.
9. Owen JJ, Harrison GA. Studies on human leucocytes in diffusion chambers on the chick chorioallantois. Transplantation 1967;5:643-651.
10. Snyderman CH, Heo DS, Johnson JT, et al. Functional and phenotypic analysis of lymphocytes in head and neck cancer T-cell markers in tumor-infiltrating lymphocytes of head and neck cancer. Arch Otolaryngol Head Neck Surg 1991;117:899-905.
11. Boyum A. Isolation of leucocytes from human blood. A two-phase system for removal of red cells with methylcellulose as erythrocyte-aggregating agent. Scand J Clin Lab Invest Suppl 1968;97:9-29.
12. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 1991;139:271-279.
13. Manzke O, Tesch H, Borchmann P, et al. Locoregional treatment of low-grade B-cell lymphoma with CD3xCD19 bispecific antibodies and CD28 costimulation. I. Clinical phase I evaluation. Int J Cancer 2001;91:508-515.
14. de Gramont A, Gangji D, Louvet C, Garcia ML, Tardy D, Romet-Lemonne JL. Adoptive immunotherapy of ovarian carcinoma. Gynecol Oncol 2002;86:102-103.
15. Armstrong PB, Quigley JP, Sidebottom E. Transepithelial invasion and intramesenchymal infiltration of the chick embryo chorioallantois by tumor cell lines. Cancer Res 1982;42:1826-1837.
16. Balzar M, Winter MJ, de Boer CJ, Litvinov SV. The biology of the 17-1A antigen (Ep-CAM). J Mol Med 1999;77:699-712.
17. Gires O, Kieu C, Fix P, et al. Tumor necrosis factor alpha negatively regulates the expression of the carcinoma-associated antigen epithelial cell adhesion molecule. Cancer 2001;92:620-628.
18. Piyathilake CJ, Frost AR, Weiss H, Manne U, Heimburger DC, Grizzle WE. The expression of Ep-CAM (17-1A) in squamous cell cancers of the lung. Hum Pathol 2000;31:482-487.
19. Lang S, Atarashi Y, Nishioka Y, Stanson J, Meidenbauer N, Whiteside TL. B7.1 on human carcinomas: costimulation of T cells and enhanced tumor-induced T-cell death. Cell Immunol 2000;201:132-143.
20. Boheim K, Denz H, Boheim C, Glassl H, Huber H. An immunohistologic study of the distribution and status of activation of head and neck tumor infiltrating leukocytes. Arch Otorhinolaryngol 1987;244:127-132.